Novel CSF biomarkers for Alzheimer’s disease and mild cognitive impairment

Altered levels of cerebrospinal fluid (CSF) peptides related to Alzheimer’s disease (AD) are associated with pathologic AD diagnosis, although cognitively normal subjects can also have abnormal levels of these AD biomarkers. To identify novel CSF biomarkers that distinguish pathologically confirmed...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hu, William T., Chen-Plotkin, Alice, Arnold, Steven E., Grossman, Murray, Clark, Christopher M., Shaw, Leslie M., Pickering, Eve, Kuhn, Max, Chen, Yu, McCluskey, Leo, Elman, Lauren, Karlawish, Jason, Hurtig, Howard I., Siderowf, Andrew, Lee, Virginia M.-Y., Soares, Holly, Trojanowski, John Q.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2880811/
https://ncbi.nlm.nih.gov/pubmed/20232070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-010-0667-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi